oncology
Medicopolitical

News in Brief: High TMB fails to predicts immunotherapy response for all cancers; Cryoablation funding for RCC; Physician chronic care model on RACP Budget wish list

High TMB fails to predicts immunotherapy response for all cancers A large analysis of patient tumour data has failed to support the use of high tumour mutational burden (TMB)  as a universal biomarker for immunotherapy response. In the most comprehensive analysis of TMB status to date researchers from the MD Anderson Cancer Center in the ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic